GB2036792A - Compounds Derived from a Bacterium and Having Antagonistic Activity - Google Patents
Compounds Derived from a Bacterium and Having Antagonistic Activity Download PDFInfo
- Publication number
- GB2036792A GB2036792A GB7847883A GB7847883A GB2036792A GB 2036792 A GB2036792 A GB 2036792A GB 7847883 A GB7847883 A GB 7847883A GB 7847883 A GB7847883 A GB 7847883A GB 2036792 A GB2036792 A GB 2036792A
- Authority
- GB
- United Kingdom
- Prior art keywords
- bacterium
- antimicrobica
- pods
- mixture
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 32
- 241000894006 Bacteria Species 0.000 title abstract description 38
- 230000003042 antagnostic effect Effects 0.000 title description 8
- 241001135516 Burkholderia gladioli Species 0.000 claims abstract description 27
- 239000000203 mixture Substances 0.000 claims abstract description 20
- 230000002538 fungal effect Effects 0.000 claims abstract description 14
- 230000001580 bacterial effect Effects 0.000 claims abstract description 12
- 239000000758 substrate Substances 0.000 claims abstract description 12
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 7
- 230000001408 fungistatic effect Effects 0.000 claims abstract description 7
- 239000003701 inert diluent Substances 0.000 claims abstract description 6
- 241001465754 Metazoa Species 0.000 claims abstract description 5
- 229920001817 Agar Polymers 0.000 claims description 11
- 239000008272 agar Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 abstract description 5
- 208000035143 Bacterial infection Diseases 0.000 abstract description 4
- 206010017533 Fungal infection Diseases 0.000 abstract description 4
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 4
- 239000002609 medium Substances 0.000 description 18
- 241000233866 Fungi Species 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 12
- 244000299461 Theobroma cacao Species 0.000 description 9
- 235000009470 Theobroma cacao Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 241000233637 Phytophthora palmivora Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000006916 nutrient agar Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241000233614 Phytophthora Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000001965 potato dextrose agar Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000624151 Pseudomonas amygdali pv. morsprunorum Species 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 241000187435 Streptomyces griseolus Species 0.000 description 2
- 241000893966 Trichophyton verrucosum Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VBUYCZFBVCCYFD-JJYYJPOSSA-N 2-dehydro-D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)C(O)=O VBUYCZFBVCCYFD-JJYYJPOSSA-N 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010082340 Arginine deiminase Proteins 0.000 description 1
- 241000893451 Arthroderma Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000194106 Bacillus mycoides Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 101100327310 Caenorhabditis elegans emb-27 gene Proteins 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000588879 Chromobacterium violaceum Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241000723247 Cylindrocarpon Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000896533 Gliocladium Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000190144 Lasiodiplodia theobromae Species 0.000 description 1
- 208000032420 Latent Infection Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000318230 Merulius Species 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 241000995680 Nannizzia Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 241000586779 Protaminobacter Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- 241001622911 Pythium graminicola Species 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000601794 Trichothecium Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000194062 Xanthomonas phaseoli Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000003516 breast abscess Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000007003 mineral medium Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001053 orange pigment Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
- A01N63/27—Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/38—Pseudomonas
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Biomedical Technology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a chemical compound or a mixture of at least two chemical compounds separated from the bacterium P. antimicrobica and having fungistatic or bacteriostatic activity. The chemical compound or the mixture may be incorporated into a composition comprising, in addition to the compound or mixture, an inert diluent or carrier. It is envisaged that P. antimicrobica and the compound or mixture separated therefrom will be useful for combatting fungal and bacterial infections of animals, humans and plants and for suppressing or controlling fungal and bacterial growth in or on substrates. Cultures of the bacterium deposited in the culture collection of the National Collection of Industrial Bacteria have been given the accession numbers 9897 and 9898.
Description
SPECIFICATION
Compounds Derived from a Bacterium and Having Antagonistic Activity
Field of the Invention
The present invention relates to a bacterium, which I have discovered exhibits antagonistic activity, to the use of the bacterium to exploit its antagonistic activity, to chemical compounds separated from the bacterium and having antagonistic activity and to the use of such compounds to exploit their antagonistic activity.
Description of the Invention
I originally isolated the bacterium from an insect virus vector, and I have named the bacterium
Pseudomonas antimicrobica.
Two cultures of P. antimicrobica were deposited in the culture collection of the National
Collection of Industrial Bacteria on 20th July 1966, and were given the accession numbers 9897 and 9898 respectively.
P. antimicrobica has the following characteristics: Cells are straight, non-sporeforming, coccoid rods, 0.5 ,nx0.8-1 .5 a occurring singly, in groups and occasionally in pairs; Gram-negative, aerobic, heterotrophic and motile with 1-2 polar flagella.
Five-day old colonies on nutrient agar are circular, raised creamy white and opaque, varying from rugose and butyrous with raised micro-undulate margins (variant NCIB 9897) to moist smooth, glistening and slightly viscid with entire margins and occasionally with an orange tinge (variant NCIB 9898). Four-day-old nutrient broth cultures show turbidity, and thin to membranous pellicles which break easily when disturbed.
A yellowish-orange water-soluble, non-fluorescent pigment, which is readily diffusable, is produced, in media A and B of King, E.O., Ward, M.K. 8 Raney, D.E. (1954), J. Lab. clin. Med. 44,301. A weakly orange pigment is produced in Czapak Dox, Nutrient and many other common laboratory agar media, but none in Potato Dextrose agar.
Growth occurs from 1 50C to 37"C with a broad optimum temperature range of 30 to 370C; There is no growth at 41 OC. Growth (NCIB 9898) also occurs in the presence of 0.5%, 2% and 4%
NaCI, with an optimum at 24%, but weakens to a trace at 6%.
Acid but not gas is produced from glucose, lactose, fructose, xylose, galactose, arabinose, manitol, dulcitol, sorbitol, glycerol and meso-inositol. There is no acid or gas production from salicin, maltose, sucrose and raffinose. Starch and ethanol are not attacked. In litmus milk the dye is slowly reduced, and a whitish sediment but not curd formed; the final pH reaction is slightly alkaline. Positive results are observed in the following tests; nitrate reduction to nitrite, lipolytic activity, egg-yolk reaction, 2-ketogluconate production, citrate utilisation, aesculin hydrolysis and malonate test; and negative results in tests for indole formation, H2S production, oxidase, arginine dihydrolase activity, accumulation of poly-/3-hydroxybutyrate and hydrolysis of gelatin and cellulose.Growth will occur in a mineral medium with a carbohydrate carbon source and with (NH4)2S04 or KNO3 as sole nitrogen source. Vitamins and growth factors are not required. A wide spectrum of antibiotic activity is demonstrated.
P. antimicrobica has fungistatic and bacteriostatic properties. Therefore, it is clear the P.
antimicrobica contains one or more chemical compounds each having, singly or in admixture with at least one other of the compounds, fungistatic or bacteriostatic activity.
The fungicidal activity referred to above included antagonistic activity towards ordinary fungal cells and fungal mycelium.
The active compounds may be simply separated from P. antimicrobica by allowing the bacterium to remain in contact with an aqueous gel, the active substances diffusing from the bacterium into the gel.
Although I am not certain of the chemical nature of the active compounds in P. antimicrobica. I believe that they are novel compounds but they have not yet been chemically analysed and thus their chemical formulae and structures are not yet known.
In a first aspect the present invention provides a chemical compound separated from P.
antimicrobica and having fungistatic or bacteriostatic activity. The compound may conveniently be present in a composition comprising, in addition to the compound, an inert diluent or carrier.
In a second aspect the present invention provides a mixture of chemical compounds separated from the bacterium P. antimicrobica and having fungistatic or bacteriostatic activity.
The mixture may conveniently be present in a composition comprising, in addition to the mixture, an inert diluent or carrier.
The inert diluent or carrier comprised in compositions according to the invention may be agar.
It is envisaged that P. antimicrobica and the above described compounds will be useful in treating various substrates to prevent or control growth of fungi or bacteria ori or in the substrates.
In particular it is envisaged that the P. antimicrobica and above-described compounds will be useful, in human and veterinary medicine, for treating humans and animals to combat fungal and bacterial infections. E.g. it is envisaged that P. antimicrobica and the compounds will be useful in treating infections and ailments in animals and humans caused by fungal or bacterial infection, such as
anthrax, thrush, breast abscesses, bovine abortion, tinea, horse ringworm and other animal ringworms.
Also, in particular, it is envisaged that P. antimicrobica and the above described compounds will
be useful in treating plants to prevent or cure bacterial and fungal infections. E.g. it is envisaged that P.
antimicrobica and the compounds will be useful in preventing P. palmivora infection in cocoa fruit and similar species of plant.
Thus, in a third aspect of the present invention, the invention provides a method of suppressing or controlling fungal or bacterial growth in or on a substrate, comprising applying to the substrate a culture of P. antimicrobica or a compound or a mixture of compounds separated from P. antimicrobica and having fungicidal or bactericidal activity.
The substrate may be one in or on which fungi or bacteria are already growing or one in or on which fungi or bacteria would be liable to grow.
The following examples are given to illustrate the antagonistic activity of compounds contained in
P. antimicrobica.
Example 1Fungicidal Activity
Cultures derived from single spores of fungi were made in petri dishes containing potato dextrose agar, Czapak Dox agar or nutrient agar and allowed to grow to a diameter of about 25 mm at 25"C.
Using a sterile standard cork borer (No. 3), small cylinders of the agar were removed 20 mm from the edge of the fungus colony, leaving holes into which measured quantities of prepared test inhibitors were placed. In other tests, a loopful of 2-day old cultures of bacterium was applied to the agar (not in holes), again 20 mm from the fungus; or was applied direct to the mycelium near the edge of the fungal colony to study invasion. Plates were incubated and increase in radial growth of the fungus towards each hole or bacterial colony measured daily, noting any stoppage of fungal growth.
Pseudomonas aeruginosa, P. maltophilia, P. an tim ycetica and P. mors-prunorum were used as controls, P. an tim ycetica examined against bacteria only.
P. antimicrobica stopped the growth of all thirty-nine species of fungi which I examined. These species included members of the Genera Phytophthora, pythium, Penicillium, Botryodiplodia,
Cylindrocarpon, Gueguenia, Ph om opsis, Fusarium, Asp ergillus, Candid, Cryptococcus, Gliocladium,
Irichophyton, Microsporum, Arthroderma, Nannizzia, Merulius, Mucor (both mating strains of M.
hiemalls), Schizosaccharomyces, Trichothecium. Some species were more susceptible to this antifungal activity than others, their growth being stopped earlier (i.e. within 24 hours). P. aeruginosa suppressed the growth of 14 species and the other bacteria did not show inhibitor activity.
The bacterium was active in all the common laboratory agar media used. Cylinders of bacteriafree agar removed from positions 20 mm from the edges of 5 day-old colonies (3 mm in diameter) inhibited fungal growth. To obtain an active diffusate, the bacterium was cultured on a quarter of the surface area of plated agar (potato dextrose, nutrient or Czapak Dox) for 7 days.
The bacteria-free portion of the agar was then cut and put into sterile bottles each containing 10 ml of sterile distilled water and left for 24 hours at room temperature. The diffusate thus obtained was tested against Phytophthora palmivora and p. infestans and found active over a pH range of 3.4-8 (buffered) which were the values examined. Zoospores and mycelia of these fungi did not grow when they were used for inoculating agar containing the active diffusate.
Example 2-Mycolytic Activity
When P. antimicrobica was inoculated in contact with fungal mycelium the filaments were often destroyed and evidently used as substrate. Often the invaded area became moist. When 3-day-old slide cultures were examined under the microscope, bacterial cells were seen inside the mycelial filaments just beyond the visible edge of the invading bacterial colony. Such mycelium did not grow when used for inoculation.
In some fungi, like Pythium graminicola, inhibition was followed by a collapse of mycelium while in others luxuriant aerial mycelium formed at the inhibited edge. The collapsed mycelium, which subsequently failed to grow when sub-cultured, appeared to indicate the point reached by a lethal concentration of the active substance secreted by the bacterium. When a plate colony of Botryodiplodia theobromae (5 cm in diameter) was ringed with a loopful of the bacterium, allowing a 5 mm-wide microbe-free zone between the two organisms, the edges of the black fungal colony began to turn transluscent within 3 days. Mycelial filaments were no longer evident in microscopical examination of the translucent areas, the surface of which was smooth and shiny; the condition suggested that the fungus was undergoing lysis due to the action of substances produced by the bacterium.
Example 3-Antibacterium Activity
Three-day-old nutrient agar cultures of eight species of bacteria, each representing a different genus, and including both Gram-positive and Gram-negative organisms were separately suspended in 0.4 ml portions of sterile distilled water. Each of the suspensions was mixed with 40 ml of melted nutrient agar at 44-450C and plated in two petri dishes, one of which was reinoculated 2025 minutes later from a suspension of P. antimicrobica and from another of P. antimycetica at separate sites; the plate which was not reinoculated served as additional control. All plates were incubated at 250C and observed for possible zones of inhibition.
Within three days, clear zones had appeared which showed P. antimicrobica to inhibit the growth of P. morsprunorum, Corynebacterium michiganse (E. F. Smith) Jensen, Xanthomonas phaseoli (E. F.
Smith) Dawson, Bacillus cereus var. mycoides (Flugge), Strep tom yces griseolus (Krainsky) Waks. 8
Henr. and Sarcina flava de Bary; but Chromobacterium violaceum (Schroeter) Bergonzini and
Protaminobacter ruber den Dooren de Jong. were not inhibited. The present species spread rapidly and produced yellowish-orange coloured diffusate in nutrient agar mixed with growing cells of P. morsprunorum, Corynebacterium michiganse or Proteminobacter ruber, and lesser amounts in the one with
Streptomyces griseolus.
Example 4 Biological Control of a Fungal Disease Using P. antimicrobica (a) Inoculation techniques
The effect of P. antimicrobica on the development of the black pod disease of cocoa caused by
Phytophthora palmivora was studied in the laboratory and in the field. To provide a satisfactory method of assay, a technique was developed in which nearly every cocoa pod inoculated with this fungus became infected. A small cylindrical piece of the outer part of the pod husk, 4 mm in diameter, was removed to a depth of about 6 mm and replaced with similar tissue of equal dimensions from a pod infected with P. palmivora. A second technique involved a modification of that of Hislop (1962):
Detached pods were chilled in an air conditioned room overnight, and transferred to a warmer room before spraying with zoospores.The necessary humid condition was provided by incubating the inoculated pod (suspended in a wire cage) inside a plastic bag into which was placed sterile wet cotton wool. The first technique ensured infection in all inoculated pods while the second was more closely related to conditions prevailing in the field.
(b) Inhibition of Infection in Detached Pods
An inoculation hole was made in each of sixty detached pods from twelve Amelonado cocoa trees. The wounds thus created in twenty of these pods which were selected at random, were each sprayed, using a sterile atomiser, with about 0.1 ml sterile semi-liquid medium (pH 5.6) comprising 0.2 g potato dextrose agar in 30 ml distilled water. Twenty more pods were sprayed in a similar manner with a 24-hour-old culture of the bacterium in the same medium. Thirty to 40 min later all pods were plug-inoculated as described above and were kept at about 270C under polyethylene sheet to conserve moisture.
Another eight pods each with an inoculation hole at the proximal, lateral and distal parts were similarly sprayed, four with medium and four with the culture. These were plug-inoculated 48 hours later.
None of the pods sprayed with the culture of the bacterium became infected irrespective of whether they were inoculated soon after spraying or 48 hour; and they remained uninfected until they ripened and were discarded. However, all the pods with no bacterial treatment developed
Phytophthora infection within 3 days at every inoculation site irrespective of position. The bacteriatreated pods showed no evidence that they were affected by the bacterium.
(c) Effect of Media on Inhibiting Activity in vivo
One hundred Amelonado cocoa pods were used in a test in which one of two inoculation holes in each of twenty-five pods was filled with uninoculated nutrient broth (Oxoid) and the other hole with a culture of the bacterium in the same medium. The same treatments were given to the next twenty-five pods but using a semi-liquid medium made up of 0.2 g potato dextrose agar in 30 ml nutrient broth, instead of nutrient broth. The second lot of fifty pods were set up similarly using another pseudomonad, 46.B, isolated from the same source as the present one. Each of the one hundred pods was plug-inoculated immediately after applying the medium or the culture.
Disease development in the pods was again inhibited by treatment with the bacterium and this showed no appreciable difference between the two media used (Table 1). The bacterium, 46.B, caused some reduction of the disease and was more effective in the semi-liquid medium than in the liquid medium.
Table 1
Comparison of the development of Phytophthora palmivora in pods in the presence and absence of two bacteria.
Percentage of infection
Liquid Semi-liquid
Treatment medium medium
Culture of present bacterium 0 8
Medium only 88 96
46.B culture 64 28
Medium only 96 84
Example 5-Reduction of Phytophthora Lesions in Unpunctured Detached Pods
Using the semi-liquid medium described in Example 4, thirty detached cocoa pods were sprayed
as follows:- 1. 10 pods: Uninoculated medium l followed by zoospore
2. 10 pods: Culture of the bacterium i suspension of P.
3. 10 pods: Uninoculated medium only. palmivora
The pods were kept at 2 7--28 OC in polyethylene bags to conserve moisture and the number of
lesions produced on them counted on the 4th day.
The bacterium again protected pods from Phytophthora infection (Table 2). Infection observed on two of the pods sprayed with the bacterium arose from the stalk end (i.e. by growth of mycelium from parent tree through the stalk).
Table 2
Reduction of zoospore infection by P. antimicrobica in uninjured pods
P. antimicrobica
Medium & culture 8 Medium only:
zoospores zoospores nozoospores Number of diseased pods out of 10 7 2 2
Total number of lesions 28 2 2
The bacterium was not found on unsprayed pods freshly collected from the field; but it was still present on pods onto which it had been sprayed 1 6 days previously, although the concentration had declined considerably by this time (Table 3).
Table 3
Decline of cell-population pods after treatment with the bacterium Time after application Number of bacterial
of bacterial culture cells per pod
6 hours 2000x106 4 days 100x 106
8 days 194X106 12 days 40x 106
16 days 32x 106 In similar tests carried out on undetached pods in the field, decline in bacterial population was faster than in the laboratory; but this could be due to rainfall which occurred during the period.
Example 6-Control of Black Pod Disease in the Field
Towards the end of the main cocoa harvesting season when ripe cocoa pods were being picked, two groups of Amelonado cocoa trees bearing a large number of both diseased and healthy mature pods were selected on a farm which had a high incidence of black pod. The first group comprised twenty trees and the second nineteen. These carried ninety-one diseased plus one hundred and twelve healthy pods, and eighty-two diseased plus one hundred and twenty-eight healthy pods respectively.
Using a low pressure sprayer all uninfected pods on alternate trees in each group were individually sprayed, to run-off, with a culture of the bacterium prepared as described above in Example 4 in a semi-liquid medium. Pods on the remaining trees were left unsprayed as controls. After allowing 12 days for any latent infection to develop the sprayed pods were observed at 2-day intervals for new black pod infections until they were ripe and harvested.
The bacterial culture reduced the percentage of pods which became diseased and prevented further infection after the 1 6th day from the date of spraying with the bacterium; unsprayed pods in both replicates, however, continued to develop infection.
Claims (8)
1. A chemical compound separated from the bacterium P. antimicrobica, as described herein, and having fungistatic or bacteriostatic activity.
2. A mixture of at least two chemical compounds separated from the bacterium P. antimicrobica, as described herein, and having fungistatic or bacteriostatic activity.
3. A composition comprising a chemical compound according to Claim 1, or a mixture according to Claim 2, together with an inert carrier or diluent.
4. A composition according to Claim 3, wherein the inert diluent or carrier is agar.
5. A method of treating a substrate to prevent or inhibit fungal or bacterial growth or growth of fungal mycelium in or on the substrate, comprising applying to the substrate the bacterium P.
antimicrobica, a compound according to Claim 1 or a mixture according to claim 2.
6. A method according to claim 5, wherein the compound or mixture is applied in a composition comprising, together with the compound or mixture, an inert diluent or carrier.
7. A method according to claim 5 or 6, wherein the substrate is a material not forming part of a living animal.
8. A method according to claim 5 or 6, wherein the substrate is a living plant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7847883A GB2036792B (en) | 1978-12-11 | 1978-12-11 | Compounds derived from a bacteruim and having antagonisticactivity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7847883A GB2036792B (en) | 1978-12-11 | 1978-12-11 | Compounds derived from a bacteruim and having antagonisticactivity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2036792A true GB2036792A (en) | 1980-07-02 |
| GB2036792B GB2036792B (en) | 1983-01-19 |
Family
ID=10501634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB7847883A Expired GB2036792B (en) | 1978-12-11 | 1978-12-11 | Compounds derived from a bacteruim and having antagonisticactivity |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2036792B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993009671A1 (en) * | 1991-11-19 | 1993-05-27 | Kemira Oy | A method to combat microbes |
| WO1995005740A1 (en) * | 1993-08-24 | 1995-03-02 | Aberdeen University | Associations of antagonistic prokaryotes with eukaryotes |
| US6376245B1 (en) | 1993-08-24 | 2002-04-23 | Aberdeen University | Associations of antagonistic prokaryotes with eukaryotes |
-
1978
- 1978-12-11 GB GB7847883A patent/GB2036792B/en not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993009671A1 (en) * | 1991-11-19 | 1993-05-27 | Kemira Oy | A method to combat microbes |
| WO1995005740A1 (en) * | 1993-08-24 | 1995-03-02 | Aberdeen University | Associations of antagonistic prokaryotes with eukaryotes |
| US6376245B1 (en) | 1993-08-24 | 2002-04-23 | Aberdeen University | Associations of antagonistic prokaryotes with eukaryotes |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2036792B (en) | 1983-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106686983B (en) | Use of bacillus methylotrophicus as plant growth stimulator and biological control element, and isolate of said species | |
| US7615366B2 (en) | Bacillus amyloliquefaciens KTGB0202 and control method of plant pathogenic fungi using that | |
| JPS63273470A (en) | Microorganism strain having antibacterial activity | |
| CZ302596A3 (en) | Preparation and method of plant disease control | |
| Larena et al. | Biological Control ofMonilinia laxaandFusarium oxysporumf. sp. lycopersiciby a Lytic Enzyme-ProducingPenicillium purpurogenum | |
| Fiddaman et al. | Screening of bacteria for the suppression of Botrytis cinerea and Rhizoctonia solani on lettuce (Lactuca sativa) using leaf disc bioassays | |
| EP0532206B1 (en) | Novel microorganisms discovered through unique process | |
| CN111849839A (en) | Preparation and application of two composite bacterial liquids for preventing and treating root knot nematode disease | |
| GB2036792A (en) | Compounds Derived from a Bacterium and Having Antagonistic Activity | |
| JP4424643B2 (en) | Method for producing antifungal agent | |
| KR100663955B1 (en) | Control and Control Methods of Rapeseed Plant Diseases | |
| CA2141413A1 (en) | A microorganism of the genus colletotrichum and its uses | |
| CN117158425A (en) | Application and inhibitor of florfenicol in preventing and treating plant bacterial diseases | |
| JP3085895B2 (en) | Novel strain belonging to Exerohilum monoceras and its use | |
| US4277462A (en) | Method for treating Dutch elm disease using P. syringae | |
| JPH02149507A (en) | Inhibiting method of leaf disease due to fungous pathogen by fungcidal bacteria and novel pure culture of said fungicidal bacteria | |
| JP2001247423A (en) | How to control lettuce disease | |
| JP2000290117A (en) | Microbial herbicide and herbicidal method | |
| US12041938B2 (en) | Composition for promoting growth of effective microorganism and controlling plant disease using prebiotics, and use thereof | |
| KR910009383B1 (en) | Antagonistic microorganisms for the control of red pepper disease and control method of red pepper disease using this antagonist | |
| RU2820703C1 (en) | Strain of micromycete penicillium crustosum ina 01369 vkpm f-1843 -antibiotic producer having antimicrobial activity to phytopathogenic fungi of genus fusarium | |
| JPH04327510A (en) | Mycotic infection inhibitor for garlic | |
| Yanti et al. | Plant growth-promoting bacteria (PGPB) consortium to control Moeller’s disease and increase shallots plant growth | |
| Singh et al. | Effect of cement dust treatment on some phylloplane fungi of wheat | |
| US3067102A (en) | Polyamidohygrostreptin and polyaminohygrostreptin antifungal process of controlling fungus diseases of the foliage of coniferous plants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 746 | Register noted 'licences of right' (sect. 46/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19941211 |